We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Elexopharm Enters Into Cardiovascular Collaboration With Merck & Co.

News   May 19, 2010

 
 Elexopharm Enters Into Cardiovascular Collaboration With Merck & Co.
 
 
 

RELATED ARTICLES

Compound Awakens Cancer Cells’ Self-destruct System

News

Researchers develop a compound that, in mice, awakened cancer cells’ "self-destruct" process, killing the cancer cells and consequently stopping their spread, while leaving "normal" cells untouched.

READ MORE

A Potential New Treatment for Preventing PTSD

News

A team of researchers has identified a protein complex that is elevated in patients with post-traumatic stress disorder (PTSD). The team have designed a peptide to target and interfere with the complex, this interference could help treat symptoms of the disorder.

READ MORE

Team Builds Drug Compounds That Block Cancer Growth

News

A team has developed new drug compounds that block the "pro-cancer" activity of FOXM1, a transcription factor that regulates the activity of dozens of genes. The compounds suppress tumor growth in both human cells and in mouse models of several types of human breast cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE